Skip to main content

Table 3 MEP latency and amplitude

From: Effects of desflurane and sevoflurane on somatosensory-evoked and motor-evoked potential monitoring during neurosurgery: a randomized controlled trial

Monitoring

Limbs

Groups

Baseline

0.3MAC

0.6MAC

0.9MAC

Latency (ms)

Upper limbs

Desflurane

28.12 ± 2.64

28.35 ± 2.69

29.50 ± 3.40

34.21 ± 6.643#

Sevoflurane

28.08 ± 2.87

28.41 ± 2.98

29.76 ± 4.03

32.13 ± 5.153

Lower limbs

Desflurane

43.63 ± 5.39

43.91 ± 5.99

45.03 ± 10.99

50.77 ± 10.063#

Sevoflurane

43.71 ± 5.64

43.87 ± 6.48

44.67 ± 6.33

47.53 ± 5.403

Amplitude (μV)

Upper limbs

Desflurane

1920.3 ± 1762.1

1303.4 ± 1455.31

590.4 ± 372.12#

273.1 ± 239.53#

Sevoflurane

1847.5 ± 1655.0

1236.1 ± 1270.71

891.0 ± 988.32

407.2 ± 254.73

Lower limbs

Desflurane

1113.2 ± 1137.0

788.9 ± 734.31#

444.7 ± 324.22#

135.0 ± 221.83#

Sevoflurane

1123.6 ± 1127.5

931.3 ± 798.41

719.9 ± 664.12

321.6 ± 298.43

  1. 1P < 0.05 versus Baseline
  2. 2P < 0.05 versus 0.3MAC
  3. 3P < 0.05 versus 0.6MAC
  4. #P < 0.05 versus Sevoflurane Group